Evidence map›Paper›PMID 32013951›Full record

ArticleBMC health services research2020

Reasons for allowing and refusing generic substitution and factors determining the choice of an interchangeable prescription medicine: a survey among pharmacy customers in Finland.

Henriikka Nokelainen, Elina Lämsä, Riitta Ahonen, Johanna Timonen

Abstract read
In one paragraph

Article in BMC health services research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Henriikka NokelainenSchool of Pharmacy / Social Pharmacy, Faculty of Health Sciences, Kuopio Campus, University of Eastern Finland, P.O.Box 1627, FI-70211, Kuopio, Finland.
Elina LämsäSchool of Pharmacy / Social Pharmacy, Faculty of Health Sciences, Kuopio Campus, University of Eastern Finland, P.O.Box 1627, FI-70211, Kuopio, Finland.
Riitta AhonenSchool of Pharmacy / Social Pharmacy, Faculty of Health Sciences, Kuopio Campus, University of Eastern Finland, P.O.Box 1627, FI-70211, Kuopio, Finland.
Johanna TimonenSchool of Pharmacy / Social Pharmacy, Faculty of Health Sciences, Kuopio Campus, University of Eastern Finland, P.O.Box 1627, FI-70211, Kuopio, Finland. johanna.timonen@uef.fi.ORCID http://orcid.org/0000-0002-5918-7493

Funding

Social Insurance Institution of Finland 3/26/2017
6 · The paper itself

Abstract

backgroundGeneric substitution (GS) was introduced in Finland in 2003 and supplemented with a reference price system (RPS) in 2009. Patients play a vital role in the acceptance of GS and the use of less expensive generic medicines. The objective of this study was to explore Finnish pharmacy customers' experience with allowing and refusing GS. Specific aims were to investigate the reasons for (1) allowing and (2) refusing GS and (3) to determine the prescription medicine-related factors influencing the customer's choice of an interchangeable prescription medicine.

methodsA questionnaire survey was conducted in February 2018. Questionnaires were handed out from 18 community pharmacies across Finland to customers ≥18 years who purchased for themselves a prescription medicine included in the RPS. A descriptive approach was used in the analysis using frequencies, the Chi-square test and Fisher's exact test.

resultsThe final study material consisted of 1043 questionnaires (response rate 40.0%). Of the customers, 47.9% had both allowed and refused GS, 41.2% had only allowed GS and 6.0% had only refused GS. Customers had allowed GS because they wanted to lower their medicine expenses (75.5%), or because the prescribed medicine (30.8%) or medicine they had used before (27.4%) was unavailable at the pharmacy. The main reasons for refusing GS were an insignificant price difference between interchangeable medicines (63.3%) and satisfaction with the medicine used before (60.2%). The main factors influencing customers' choice of an interchangeable prescription medicine were price (81.1%), familiarity (38.4%) and availability (32.8%). Customers who had allowed GS chose the medicine based on price. Customers who had only refused GS appreciated familiarity more than the price of the medicine.

conclusionsGS is a common practice in Finnish community pharmacies. The price of the medicine was the most important factor affecting customers' decision to allow or refuse GS and the choice of an interchangeable prescription medicine. Thus, customers should receive information about medicine prices at the pharmacy in order to help them make their decision. However, individual needs should also be taken into account in counselling because customers regard several factors as important in their choice of an interchangeable medicine.

Indexed as

Drug SubstitutionPrescription DrugsAdolescentAdultAgedAged, 80 and overCommerceConsumer BehaviorDrugs, GenericFemaleFinlandHumansMaleMiddle AgedPharmaciesSurveys and QuestionnairesDrugs, GenericPrescription DrugsChoice of medicineCommunity pharmacyCustomerExperienceGeneric substitutionInterchangeable prescription medicineReference price systemSurvey

Identifiers

PMID32013951
PMCPMC6998302

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.